AlphaStocks
5.5
Consider Buy

PTC THERAPEUTICS, INC. (PTCT)

Health Care / Pharmaceuticals

S&P SmallCap 600

$68.74

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#447out of 1127 in Health Care

Is PTC THERAPEUTICS, INC. a Good Investment in 2026?

PTC THERAPEUTICS, INC. (PTCT) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates PTC THERAPEUTICS, INC. as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Top 25% (rank 18%). PTC THERAPEUTICS, INC. ranks #447 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-23.6Market Cap6B

Valuation

Trades at 8893x earnings — significantly above sector median of 25x. Premium reflects market growth expectations.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Top 25% (rank 18%)

Frequently Asked Questions

Is PTC THERAPEUTICS, INC. (PTCT) a good investment?
Based on AlphaStocks' composite analysis, PTC THERAPEUTICS, INC. (PTCT) scores 5.5 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trades at 8893x earnings — significantly above sector median of 25x. Premium reflects market growth expectations.
What is PTC THERAPEUTICS, INC.'s Piotroski F-Score?
PTC THERAPEUTICS, INC.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PTCT overvalued or undervalued?
A precise fair value estimate is not available for PTCT. Trades at 8893x earnings — significantly above sector median of 25x. Premium reflects market growth expectations.
How does PTCT compare to other Health Care stocks?
PTC THERAPEUTICS, INC. ranks #447 out of 1127 stocks in the Health Care sector, placing it in the top 40% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about PTCT?
AlphaStocks evaluates PTCT using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.5/10.

Similar Stocks

PARRFTIAZN

Compare PTCT with

PTCT vs PARRPTCT vs FTIPTCT vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer